EDIT vs HLT · rev $32.3M vs P/E 51, rev $11.17B
Editas Medicine Inc (EDIT) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported HLT revenue for 2024-12-31 was $11.17B. Net income was $1.54B. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
EDIT currently screens at market cap $375.2M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Not investment advice. Open the EDIT and HLT stock pages for the full models.
Not investment advice.